Cargando…

Survivin Promotes Piperlongumine Resistance in Ovarian Cancer

Ovarian cancer is one of the most fatal female malignancies while targeting apoptosis is critical for improving ovarian cancer patients' lives. Survivin is regarded as the most robust anti-apoptosis protein, and its overexpression in ovarian cancer is related to poor survival and apoptosis resi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nan, Xing-Wei, Gong, Li-Hua, Chen, Xu, Zhou, Hai-Hong, Ye, Piao-Piao, Yang, Yang, Xing, Zi-Hao, Wei, Meng-Ning, Li, Yao, Wang, Sheng-Te, Liu, Kun, Shi, Zhi, Yan, Xiao-Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895030/ https://www.ncbi.nlm.nih.gov/pubmed/31850227 http://dx.doi.org/10.3389/fonc.2019.01345

Ejemplares similares

Celastrol Inhibits the Growth of Ovarian Cancer Cells in vitro and in vivo
por: Xu, Li-Na, et al.
Publicado: (2019)

Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer
por: Huang, Jia-Rong, et al.
Publicado: (2020)

Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer
por: Zhou, Hai-Hong, et al.
Publicado: (2019)

Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance
por: Wang, Kun, et al.
Publicado: (2019)

Piperlongumine Induces Apoptosis and Synergizes with Cisplatin or Paclitaxel in Human Ovarian Cancer Cells
por: Gong, Li-Hua, et al.
Publicado: (2014)

Identification of Piperlongumine as Potent Inhibitor of Necroptosis
por: He, Xiaoyan, et al.
Publicado: (2023)

miR-936 Suppresses Cell Proliferation, Invasion, and Drug Resistance of Laryngeal Squamous Cell Carcinoma and Targets GPR78
por: Lin, Xi-Jun, et al.
Publicado: (2020)

Preformulation Studies on Piperlongumine
por: Aodah, Alhassan, et al.
Publicado: (2016)

Oxymatrine and Cisplatin Synergistically Enhance Anti-tumor Immunity of CD8(+) T Cells in Non-small Cell Lung Cancer
por: Ye, Jin, et al.
Publicado: (2018)

Metabolic profile and safety of piperlongumine
por: de Lima Moreira, Fernanda, et al.
Publicado: (2016)

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma
por: Huang, Shan-Zhou, et al.
Publicado: (2019)

WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling Cascade
por: Huang, Shiu-Wen, et al.
Publicado: (2019)

The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress
por: Chen, WeiQian, et al.
Publicado: (2019)

Design, synthesis and biological evaluation of selective survivin inhibitors
por: Xiao, Min, et al.
Publicado: (2019)

Correlation between survivin polymorphism and acute leukemia of children
por: Li, Wei-Xi, et al.
Publicado: (2018)

Piperlongumine Is an NLRP3 Inhibitor With Anti-inflammatory Activity
por: Shi, Jie, et al.
Publicado: (2022)

Discovering and Characterizing of Survivin Dominant Negative Mutants With Stronger Pro-apoptotic Activity on Cancer Cells and CSCs
por: Guo, Wei, et al.
Publicado: (2021)

DCE-MRI radiomics models predicting the expression of radioresistant-related factors of LRP-1 and survivin in locally advanced rectal cancer
por: Li, Zhiheng, et al.
Publicado: (2022)

AZ32 Reverses ABCG2-Mediated Multidrug Resistance in Colorectal Cancer
por: Liu, Kun, et al.
Publicado: (2021)

Piperlongumine-Induced Phosphatidylserine Translocation in the Erythrocyte Membrane
por: Bissinger, Rosi, et al.
Publicado: (2014)

Piperlongumine promotes death of retinoblastoma cancer cells
por: Allaman-Pillet, Nathalie, et al.
Publicado: (2021)

The promising potential of piperlongumine as an emerging therapeutics for cancer
por: Parama, Dey, et al.
Publicado: (2021)

Rare Recurrent EWSR1-PLAGL1 Rearranged Intracranial Tumor With Biphasic Epithelioid Differentiation: One Case Report With Literature Review
por: Xing, Ai-yan, et al.
Publicado: (2022)

Piperlongumine induces autophagy by targeting p38 signaling
por: Wang, Y, et al.
Publicado: (2013)

An artificial intelligence prediction model outperforms conventional guidelines in predicting lymph node metastasis of T1 colorectal cancer
por: Piao, Zheng Hua, et al.
Publicado: (2023)

Natural product piperlongumine inhibits proliferation of oral squamous carcinoma cells by inducing ferroptosis and inhibiting intracellular antioxidant capacity
por: Wang, Zi-Qian, et al.
Publicado: (2022)

Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients
por: Ge, Ming-Yang, et al.
Publicado: (2023)

Piperlongumine and immune cytokine TRAIL synergize to promote tumor death
por: Li, Jiahe, et al.
Publicado: (2015)

Piperlongumine Inhibits Thioredoxin Reductase 1 by Targeting Selenocysteine Residues and Sensitizes Cancer Cells to Erastin
por: Yang, Yijia, et al.
Publicado: (2022)

Efficacy and Prognostic Factors for PARP Inhibitors in Patients With Ovarian Cancer
por: Huang, Xuan-zhang, et al.
Publicado: (2020)

Expression and clinical significance of survivin in ovarian cancer: A meta-analysis
por: He, Xiaoyan, et al.
Publicado: (2018)

TIMELESS Promotes Tumor Progression by Enhancing Macrophages Recruitment in Ovarian Cancer
por: Xing, Xin, et al.
Publicado: (2021)

Piperlongumine and p53-Reactivator APR-246 Selectively Induce Cell Death in HNSCC by Targeting GSTP1
por: Hang, Wei, et al.
Publicado: (2018)

Genomic profiling and immune landscape of olfactory neuroblastoma in China
por: Yang, Yunyun, et al.
Publicado: (2023)

Clinical Efficacy of Immune Checkpoint Inhibitors in Older Non-small-Cell Lung Cancer Patients: A Meta-Analysis
por: Sun, You-Meng, et al.
Publicado: (2020)

Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells
por: Li, Yi-Dong, et al.
Publicado: (2020)

Hypoxia potentiates the cytotoxic effect of piperlongumine in pheochromocytoma models
por: Bullova, Petra, et al.
Publicado: (2016)

Biological and physical approaches on the role of piplartine (piperlongumine) in cancer
por: Henrique, Tiago, et al.
Publicado: (2020)

A Combined Long Noncoding RNA Signature as a Candidate Prognostic Biomarker for Ovarian Cancer
por: Li, Hui, et al.
Publicado: (2021)

Effect and Safety of Therapeutic Regimens for Patients With Germline BRCA Mutation-Associated Breast Cancer: A Network Meta-Analysis
por: Jiang, Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bl2rs76cp8smjnfeffr1vs99ke